ZA919732B - Progestogen-only contraceptive - Google Patents
Progestogen-only contraceptiveInfo
- Publication number
- ZA919732B ZA919732B ZA919732A ZA919732A ZA919732B ZA 919732 B ZA919732 B ZA 919732B ZA 919732 A ZA919732 A ZA 919732A ZA 919732 A ZA919732 A ZA 919732A ZA 919732 B ZA919732 B ZA 919732B
- Authority
- ZA
- South Africa
- Prior art keywords
- ketodesogestrel
- desogestrel
- regimen
- oral contraceptive
- progestogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP90203371 | 1990-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA919732B true ZA919732B (en) | 1992-09-30 |
Family
ID=8205203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA919732A ZA919732B (en) | 1990-12-17 | 1991-12-10 | Progestogen-only contraceptive |
Country Status (20)
Country | Link |
---|---|
US (1) | US5461041A (xx) |
EP (1) | EP0491443B1 (xx) |
JP (1) | JPH04290829A (xx) |
KR (1) | KR100221008B1 (xx) |
CN (1) | CN1036834C (xx) |
AT (1) | ATE135218T1 (xx) |
AU (1) | AU649082B2 (xx) |
CA (1) | CA2057714C (xx) |
DE (2) | DE19975011I2 (xx) |
DK (1) | DK0491443T3 (xx) |
ES (1) | ES2087237T3 (xx) |
FI (1) | FI98984C (xx) |
GR (1) | GR3020180T3 (xx) |
IE (1) | IE71202B1 (xx) |
LU (1) | LU90341I2 (xx) |
NL (1) | NL990003I2 (xx) |
NO (2) | NO2002013I2 (xx) |
NZ (1) | NZ240969A (xx) |
PT (1) | PT99818B (xx) |
ZA (1) | ZA919732B (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4133680A1 (de) * | 1991-10-11 | 1993-04-15 | Metallgesellschaft Ag | Stabilisierte staerke, verwendung der stabilisierten staerke und verfahren zu ihrer herstellung |
DE4227989A1 (de) * | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
US5395627A (en) * | 1992-09-04 | 1995-03-07 | Akzo N.V. | Pharmaceutical granulate |
US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
ZA949929B (en) * | 1993-12-23 | 1995-08-23 | Akzo Nobel Nv | Sugar-coated pharmaceutical dosage unit. |
DE4405590C1 (de) * | 1994-02-22 | 1995-07-20 | Hesch Rolf Dieter Prof Dr Med | Mittel zur postmenopausalen Hormonbehandlung |
DK0782449T3 (da) * | 1994-09-22 | 2003-08-04 | Akzo Nobel Nv | Fremgangsmåde til fremstilling af doseringsenheder ved vådgranulering |
US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
AU4134599A (en) * | 1998-04-07 | 1999-10-25 | Akzo Nobel N.V. | Progestogen-only contraceptive kit |
AU5619399A (en) * | 1998-08-11 | 2000-03-06 | Akzo Nobel N.V. | Progestogen-only contraceptive kit providing good cycle control |
US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US20050113351A1 (en) * | 2000-03-21 | 2005-05-26 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US20040176336A1 (en) * | 2000-03-21 | 2004-09-09 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
GB0114746D0 (en) | 2001-06-16 | 2001-08-08 | Boots Co Plc | Medicinal composition |
US6574033B1 (en) | 2002-02-27 | 2003-06-03 | Iridigm Display Corporation | Microelectromechanical systems device and method for fabricating same |
TW200403075A (en) * | 2002-05-29 | 2004-03-01 | Akzo Nobel Nv | Progestagenic dosage units |
AU2004234057A1 (en) * | 2003-04-29 | 2004-11-11 | Akzo Nobel N.V. | Antisolvent solidification process |
DE102005053771A1 (de) * | 2005-11-09 | 2007-05-10 | Grünenthal GmbH | Darreichform zur hormonalen Kontrazeption |
DE202010010589U1 (de) | 2010-07-22 | 2010-10-14 | Bayer Schering Pharma Aktiengesellschaft | Estrogenfreie Formulierung zur oralen Kontrazeption, bevorzugt verwendbar für Frauen mit bewusster/unbewusster Laktoseintoleranz oder mit bewusster laktosefreier Kontrazeption |
EP2730284A1 (en) * | 2012-11-12 | 2014-05-14 | Naari AG | Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation |
WO2017000081A1 (zh) * | 2015-06-30 | 2017-01-05 | 上海交通大学 | Etonogestrel在制备抗前列腺癌产品中的应用 |
US11679114B2 (en) | 2021-07-26 | 2023-06-20 | Navad Life Sciences Pte | Progestogen-only oral contraception |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4066757A (en) * | 1973-03-26 | 1978-01-03 | Ortho Pharmaceutical Corporation | Oral contraceptive regimen |
DE19975054I2 (de) * | 1987-08-08 | 2000-04-13 | Akzo Nobel Nv | Kontrazeptives Implantat |
-
1991
- 1991-12-09 IE IE427191A patent/IE71202B1/en not_active IP Right Cessation
- 1991-12-10 ZA ZA919732A patent/ZA919732B/xx unknown
- 1991-12-12 DE DE1999175011 patent/DE19975011I2/de active Active
- 1991-12-12 DK DK91203328.9T patent/DK0491443T3/da active
- 1991-12-12 EP EP91203328A patent/EP0491443B1/en not_active Expired - Lifetime
- 1991-12-12 ES ES91203328T patent/ES2087237T3/es not_active Expired - Lifetime
- 1991-12-12 DE DE69117902T patent/DE69117902T2/de not_active Expired - Lifetime
- 1991-12-12 AT AT91203328T patent/ATE135218T1/de not_active IP Right Cessation
- 1991-12-13 AU AU89678/91A patent/AU649082B2/en not_active Expired
- 1991-12-13 NZ NZ240969A patent/NZ240969A/en not_active IP Right Cessation
- 1991-12-16 NO NO2002013C patent/NO2002013I2/no unknown
- 1991-12-16 CA CA002057714A patent/CA2057714C/en not_active Expired - Lifetime
- 1991-12-16 NO NO914970A patent/NO178686C/no not_active IP Right Cessation
- 1991-12-16 FI FI915913A patent/FI98984C/fi active
- 1991-12-16 KR KR1019910023066A patent/KR100221008B1/ko not_active IP Right Cessation
- 1991-12-16 PT PT99818A patent/PT99818B/pt not_active IP Right Cessation
- 1991-12-17 CN CN91107997A patent/CN1036834C/zh not_active Expired - Lifetime
- 1991-12-17 JP JP3333717A patent/JPH04290829A/ja active Pending
-
1994
- 1994-01-19 US US08/183,644 patent/US5461041A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 GR GR960401542T patent/GR3020180T3/el unknown
-
1999
- 1999-01-22 NL NL990003C patent/NL990003I2/nl unknown
- 1999-01-27 LU LU90341C patent/LU90341I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU649082B2 (en) | Progestagen-only contraceptive | |
NZ234051A (en) | Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity | |
EP0136011A3 (en) | A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor | |
PT85305A (en) | Method for providing hormonal replacement therapy and contraception for a pre-menopausal woman using a combination dosage form of an estrogen and a progestogen | |
IL122109A0 (en) | A two-stage pharmaceutical preparation for hormonal contraception and a kit containing the same | |
MX9804395A (es) | Proceso y equipo anticonceptivos para mamiferos hembra, que comprenden una combinacion de gestageno y estrogeno. | |
BG101427A (en) | Competitive progesterone antagonists for regulating female fertility as required | |
MX9707009A (es) | Inyeccion de una vez al mes como un contraceptivo de base y para terapia de reemplazamiento hormonal para mujeres perimenopausicas y premenopausicas. |